reviewTop 1% cited
High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
International Journal of Cardiology · 2013 · Vol. 168(6) · pp. 5126–5134
Wolfgang Köenig✉(Universität Ulm)
Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesMedicineCanakinumabInflammationC-reactive proteinInternal medicineStatinClinical trialDiseaseRandomized controlled trialAcute-phase protein
MeSH terms
C-Reactive ProteinHumansRisk FactorsBiomarkersRisk AssessmentAtherosclerosis
Citations
315
FWCI
13.23
field-weighted impact
References
106
Percentile
99%
vs. same field & year
Citations per year
Cited by
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis
Atherosclerosis · 2017 · 426 citations
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis · 2019 · 4,829 citations
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
European Heart Journal · 2019 · 8,581 citations
References
C-reactive protein: a critical update
Journal of Clinical Investigation · 2003 · 3,498 citations
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
Atherosclerosis · 2001 · 375 citations
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
American Heart Journal · 2011 · 786 citations
Inflammation, Atherosclerosis, and Coronary Artery Disease
New England Journal of Medicine · 2005 · 8,682 citations
Lipoprotein(a) as a cardiovascular risk factor: current status
European Heart Journal · 2010 · 1,758 citations
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 735 citations
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
European Heart Journal · 2003 · 5,274 citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
New England Journal of Medicine · 2008 · 6,562 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.